IRCT20100228003449N30招募中2 期
Evaluating efficacy and safety of hydroxychloroquine + lopinavir or atazanavir/ritonavir combination in patients with COVID-19
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with highly suspected or confirmed COVID-19 who are candid for hospitalization and starting triple-drug combination
排除标准
- •History of drug allergy
研究者
相似试验
招募中
1 期
Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19COVID-19.COVID-19U07.1IRCT20150808023559N20Ardabil University of Medical Sciences100
已完成
3 期
Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19IRCT20200318046812N1Iran University of Medical Sciences324
招募中
3 期
Treatment of Hydroxychloroquine in Type 2 Diabetes Patients Uncontrolled on Metformin MonotherapyCTRI/2021/11/037750Ipca Laboratories Ltd
招募中
3 期
Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxisCOVID-19 pneumonia.COVID-19, virus not identifiedU07.2IRCT20130917014693N10Shahid Beheshti University of Medical Sciences100
招募中
4 期
A Clinical Trial to Study the Safety and Efficacy of Hydroxychloroquine in Patients with Type-2 DaibetesCTRI/2016/02/006599Ipca Laboratories Ltd600